Skip to content

How to efficiently characterize the interaction pathways of protein-ligand recognition? A comparative analysis on enhanced sampling approaches.

Jan 2026 · Journal of Chemical Physics · Vol 164 2 · 1 citation · 44 references
Medicine

TL;DR

These results suggest that it will be much time-saving to utilize RAMD with high random force for interaction pathway exploration for both the pathway obvious and unobvious systems if the protein keeps stable in the simulation if the protein keeps stable in the simulation.

Abstract

It is evidenced that many elaborately designed molecules that can interact well with the binding pocket of their target fail to exhibit activity in wet-lab experiments. This may associate with the interacting process of drug-target recognition. To efficiently characterize the drug-target interacting process, various enhanced sampling technologies have been proposed; yet, very few studies have systemically investigated whether the settings of these simulations are favorable to characterize the purposed tasks. Here, by comparing two popular enhanced sampling technologies, namely, the well-temped metadynamics and random acceleration molecular dynamics (RAMD), we systemically investigate the strategies to efficiently characterize the dissociating process of protein-ligand interactions. Two target families are employed for the analysis, including the kinase family (represented by TRK1) that represents the interaction-pathway obvious systems and the nuclear receptor family (represented by THRβ) that represents the interaction-pathway unobvious systems. Our results suggest that (1) in terms of maintaining stability of the protein structure, MetaD at various simulation conditions and RAMD with a large random force are good choice; (2) drug residence time derived from both MetaD and RAMD based on various parameters shows reasonable correlation to the experimental binding strength of the ligands, but RAMD usually runs with much less simulation time; and (3) both enhanced sampling methods result in reasonably consistent pathway preference for the two target families. Taken together, it will be much time-saving to utilize RAMD with high random force for interaction pathway exploration for both the pathway obvious and unobvious systems if the protein keeps stable in the simulation; otherwise, MetaD with a high bias factor is proposed to balance the computational accuracy and efficiency for the exploration.

View source

Similar papers

Aug 2026

Exploring Competitive Protein-Protein Interaction Mechanisms through Dynamic Residue Energy Landscapes for Antizyme Design and Validation.

This work uncovers key dynamic features of the static and recognition pathway interaction of the ornithine decarboxylase-antizyme isoforms system and reveals critical determinants of binding specificity and partner selection that static structures alone cannot capture.

Baolin Guo, Qian Xue, Fan Yang et al. · 0 citations
Open access Sep 2026

Structural determinants of Mac1 inhibition: Lessons from ligand binding patterns.

It is suggested that targeting both the oxyanion hole and Leu126 may enhance both the specificity and affinity of next-generation Mac1 inhibitors.

Verena Weber, Sarah Knapp, Patricia Korn et al. · 0 citations
Open access Aug 2026

Profiling Protein‐Peptide Interactions by Yeast Surface Display

A protocol for discovering protein‐binding peptides using a very large, target‐agnostic yeast surface display library containing approximately 6.1 × 109 unique clones and providing broad coverage of short peptide sequence space is described.

J. D. Hurley, Andrew C. Kruse · 0 citations
Sep 2026

Performances and Critical Limitations of Docking and Protein–Ligand Interactions for Efficacy-Driven Virtual Screening Targeting Class A GPCRs

A comprehensive assessment based on systematic benchmarking using a diverse set of class A G-protein-coupled receptors and different approaches to represent protein–ligand demonstrates that the combined approach overall improves the efficacy bias of selected ligands as compared to docking alone.

Luca Chiesa, G. Bret, Severine Schneider et al. · 0 citations
Open access Aug 2026

Dissecting the binding landscape of four cKIT inhibitors through an integrated multifaceted approach.

This work highlights how distinct inhibitors exploit different conformational states of cKIT and demonstrates the value of integrating structural analyses, biophysical measurements, calculations and molecular simulations to define the mechanism of kinase inhibition.

Irene Cipollone, Carmen Gratteri, C. Talarico et al. · 0 citations
Open access Aug 2026

PAM-DB: Revealing Protein Activation Mechanisms for Next-Generation Rational Drug Discovery

A structural database that systematically maps the complete activation trajectories of pharmaceutically relevant targets, encompassing TS, IS, and all connecting conformational ensembles is presented, offering multiple strategic advantages for drug discovery.

Xiaohong Zhu, Xiangyu Li, Yaning Hou et al. · 0 citations

Related blog posts

MIT News · Artificial Intelligence Oct 15, 2026

AI model decodes the language cells use to communicate

A new computational approach reveals how cells communicate to assemble into tissues. This could accelerate stem cell engineering, improve disease models, and inform therapies.

Microsoft Research Blog Oct 15, 2026

Proof-based general-purpose computing with Magnetar

Zero-knowledge proofs can verify computing results without rerunning workloads or exposing sensitive data. Magnetar helps bring them into the mainstream with support for standard programming languages, major speed gains, and quantum-resistant security. The post Proof-based general-purpose computing with Magnetar appeared first on Microsoft Research.

MIT News · Artificial Intelligence Aug 27, 2026

Looking beyond natural sequences

A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.